Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Ryan J. Watts, PhD$2.4B
Market Cap • 07/05/20242013
(há 11 anos)
2017
(7 years ago)
NASDAQ
Listagem
South San Francisco
Sede • California427
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
DNLISó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.